Evidence map›Paper›PMID 40281006›Full record

ArticleScientific reports2025

A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy.

Xiaotian Ma, Yu-Chun Hsu, Amma Asare, Kai Zhang, Deanna Glassman, Katelyn F Handley, Katherine Foster, Khwahish Sharma, Shannon Westin, Amir Jazaeri and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xiaotian Ma *McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Yu-Chun Hsu *McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Amma Asare *Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kai ZhangMcWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Deanna GlassmanDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Katelyn F HandleyDepartment of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Katherine FosterCHI Saint Joseph Medical Care, Lexington, KY, USA.
Khwahish SharmaDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shannon WestinDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Amir JazaeriDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nicole D FlemingDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pratip K BhattacharyaDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Xiaoqian JiangMcWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Anil K SoodDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shayan ShamsMcWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA. shayan.shams@uth.tmc.edu.

Funding

AIM-AI: an Actionable, Integrated and Multiscale genetic map of Alzheimer's disease via deep learningU01AG079847 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Christopher A. Gaiteri, Xiaoqian Jiang · 2023 to 2026
$5.1M
Decentralized differentially-private methods for dynamic data release and analysisR01LM013712 · NLM · YALE UNIVERSITY · PI JIANG, XIAOQIAN, OHNO-MACHADO, LUCILA · 2022 to 2025
$2.5M
Harmonizing multiple clinical trials for Alzheimer's disease to investigate differential responses to treatment via federated counterfactual learningR01AG082721 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Xiaoqian Jiang, Yejin Kim · 2023 to 2026
$2.0M
Robust privacy preserving distributed analysis platform for cancer research: addressing data bias and disparitiesU01CA274576 · NCI · UNIVERSITY OF PENNSYLVANIA · PI JIANG, XIAOQIAN, LONG, QI · 2023 to 2025
$1.2M
Cancer Prevention and Research Institute of Texas RR180012NCI NIH HHS U01 CA274576NIA NIH HHS R01 AG082721NIA NIH HHS U01 AG079847NIH HHS R01LM013712NLM NIH HHS R01 LM013712Ovarian Cancer Research Alliance CRDGAI-2023-3-1002
6 · The paper itself

Abstract

Ovarian cancer is associated with high rates of patient mortality and morbidity. Laparoscopic assessment of tumor localization can be used for treatment planning in newly diagnosed high-grade serous ovarian carcinoma (HGSOC). While spread to multiple intra-abdominal areas is correlated with worse outcomes, whether other morphological tumor differences are also associated with patient outcomes is unknown. Given the large volume of visual information in laparoscopic videos, we investigated whether deep-learning models can capture implicit features and predict treatment outcomes. We developed a novel deep-learning framework using pre-treatment laparoscopic images to assess clinical outcomes following upfront standard treatment, defined as short progression-free survival (PFS) (< 8 months) or long PFS (> 12 months). The deep-learning framework consisted of contrastive pre-training to capture morphological features of images and a location-aware transformer to predict patient-level treatment outcomes. We trained and extensively evaluated the model using cross-validation and analyzed the extracted features via UMAP visualizations and Grad-CAM saliency maps. The model reached an AUROC of 0.819 (± 0.119) on fivefold cross-validation and an out-of-fold AUROC of 0.807 on the whole dataset, successfully discriminating between patients with short PFS and long PFS using only laparoscopic images. Our approach demonstrates the potential of deep learning to simplify HGSOC triage and improve early treatment planning by accurately stratifying the patients based on minimally invasive laparoscopy at the diagnostic stage.

Indexed as

Artificial IntelligenceLaparoscopyOvarian NeoplasmsAgedDeep LearningFemaleHumansMiddle AgedTreatment OutcomeDeep learningLaparoscopyOutcome predictionOvarian cancerProgression-free survivalSelf-supervised learning

Identifiers

PMID40281006
PMCPMC12032350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.